Tampa Bay Times Blows the Lid on Crooked Charities

The results of a yearlong investigation conducted by both the Tampa Bay Times and The Center for Investigative Reporting is shaking the foundations of some really crummy foundations.

The investigators looked into several thousand national charities to see which were spending the most and the least on direct patient care or advocacy.

They created a list of the 50 worst charities. By what criteria? They looked at how much of each dollar donated actually goes towards the cause the charity claims to support, and how much of each dollar is diverted to pay for-profit companies to drum up fundraisers to make them more money.

In some cases, the worst charities put no more than few cents of every dollar towards helping those in need.

Combined, the 50 worst charities squandered almost $1 billion that should have gone towards patients on paying companies to help them raise money. In some cases, these companies were owned by the members of the same family that ran the charity.

In the worst 50, predictably, there are 10 cancer charities (the number signifies where the charity ranked among the worst):

You can read the Bay Times report here.

It's no coincidence that the names of these charities sound so similar to more reputable ones. That makes this situation that much more disgusting.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap